| SZ CAT No: | CL-OFX-08 |
| CAS No: | 104721-52-0 |
| Mol.F: | C18H20FN3O5 |
| Mol.Wt.: | 377.4 |
| Chemical Name: | 4-[(3RS)-6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazin-10-yl]-1-methylpiperazine 1-oxide |
| SMILES: | Smiles Not Available |
| Inventory Status: | In Stock |
This impurity is related to Ofloxacin EP Impurity F is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Ofloxacin EP Impurity F is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:4-[(3RS)-6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazin-10-yl]-1-methylpiperazine 1-oxideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Ofloxacin Molecular Formula: C18H20FN3O5
Molecular Weight: 377.4
Storage: Store in a cool, dry place.
Cat. No: CL-OFX-NO-01
CAS No: NA
Mol. F: C5H11N3O
Mol. Wt: 129.09
Inv. Status: In Stock
Cat. No: CL-OFX-NO-02
CAS No: NA
Mol. F: C17H17FN4O5
Mol. Wt: 376.34
Inv. Status: In Stock
Cat. No: CL-OFX-NO-03
CAS No: NA
Mol. F: C16H17FN4O3
Mol. Wt: 332.34
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-NO-04
CAS No: NA
Mol. F: C17H18N4O5
Mol. Wt: 358.35
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-NO-05
CAS No: NA
Mol. F: C17H17FN4O5
Mol. Wt: 376.34
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-NO-07
CAS No: NA
Mol. F: C19H21FN4O5
Mol. Wt: 404.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-01
CAS No: 82419-36-1
Mol. F: C18H20FN304
Mol. Wt: 361.4
Inv. Status: In Stock
Cat. No: CL-OFX-02
CAS No: 82419-35-0
Mol. F: C13H9F2NO4
Mol. Wt: 281.2
Inv. Status: In Stock
Cat. No: CL-OFX-03
CAS No: 123155-82-8
Mol. F: C17H20FN3O2
Mol. Wt: 317.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-04
CAS No: 95848-94-5
Mol. F: C18H21N3O4
Mol. Wt: 343.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-05
CAS No: 197291-75-1
Mol. F: C18H20FN3O4
Mol. Wt: 361.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-06
CAS No: 2172959-66-7
Mol. F: C20H24FN3O4
Mol. Wt: 389.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-07
CAS No: 82419-52-1
Mol. F: C17H18FN3O4
Mol. Wt: 347.3
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-09
CAS No: 1797983-25-5
Mol. F: C16H18FN3O4 : HCl
Mol. Wt: 335.3 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-10
CAS No: 100986-86-5
Mol. F: C18H20FN3O4
Mol. Wt: 361.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-11
CAS No: 56346-18-0
Mol. F: C13H10FNO4
Mol. Wt: 263.2
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-12
CAS No: 1346617-10-4
Mol. F: C18H17D3FN3O4
Mol. Wt: 364.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-13
CAS No: NA
Mol. F: C18H12D8FN3O4
Mol. Wt: 369.4
Inv. Status: Custom Synthesis
Cat. No: CL-OFX-14
CAS No: 2489671-28-3
Mol. F: C18H20FN3O4
Mol. Wt: 361.4
Inv. Status: Custom Synthesis
| CAT No: | CL-OFX-08 |
| CAS No: | 104721-52-0 |
| Mol.F: | C18H20FN3O5 |
| Mol.Wt: | 377.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: